CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma

Lin Liua Graduate School, Jinan University, Jinan, People’s Republic of China;b Department of Hematology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-6417-6393

Feng Zhangb Department of Hematology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of China

Jiajia Lib Department of Hematology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of China

Pages 716-723 | Published online: 23 Sep 2021

Cite this article
https://doi.org/10.1080/16078454.2021.1974199
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:https://doi.org/10.3322/caac.21590.
PubMed Web of Science ®Google Scholar
Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385(9983):2197–2208. doi:https://doi.org/10.1016/S0140-6736(14)60493-1.
PubMed Web of Science ®Google Scholar
Joshua DE, Bryant C, Dix C, et al. Biology and therapy of multiple myeloma. Med J Aust. 2019;210(8):375–380. doi:https://doi.org/10.5694/mja2.50129.
PubMed Web of Science ®Google Scholar
Hideshima T, Mitsiades C, Tonon G, et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer. 2007;7(8):585–598. doi:https://doi.org/10.1038/nrc2189.
PubMed Web of Science ®Google Scholar
Landgren O, Rajkumar SV. New developments in diagnosis, prognosis, and assessment of response in multiple myeloma. Clin Cancer Res. 2016;22(22):5428–5433. doi:https://doi.org/10.1158/1078-0432.CCR-16-0866.
PubMed Web of Science ®Google Scholar
Levin A, Hari P, Dhakal B. Novel biomarkers in multiple myeloma. Transl Res. 2018;201:49–59. doi:https://doi.org/10.1016/j.trsl.2018.05.003.
PubMed Web of Science ®Google Scholar
Gupta N, Sharma A. Emerging biomarkers in multiple myeloma: a review. Clin Chim Acta. 2020;503:45–53. doi:https://doi.org/10.1016/j.cca.2019.12.026.
PubMed Web of Science ®Google Scholar
Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:https://doi.org/10.1038/s41576-019-0158-7.
PubMed Web of Science ®Google Scholar
Wu Z, Sun H, Li J, et al. Circular RNAs in leukemia. Aging (Albany NY). 2019;11(13):4757–4771. doi:https://doi.org/10.18632/aging.102091.
PubMedGoogle Scholar
Chen X, Yang T, Wang W, et al. Circular RNAs in immune responses and immune diseases. Theranostics. 2019;9(2):588–607. doi:https://doi.org/10.7150/thno.29678.
PubMed Web of Science ®Google Scholar
Kristensen LS, Hansen TB, Veno MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:https://doi.org/10.1038/onc.2017.361.
PubMed Web of Science ®Google Scholar
Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900. doi:https://doi.org/10.1038/s41419-019-2089-9.
PubMed Web of Science ®Google Scholar
Sang Y, Chen B, Song X, et al. CircRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27(9):1638–1652. doi:https://doi.org/10.1016/j.ymthe.2019.05.011.
PubMed Web of Science ®Google Scholar
Lu Q, Liu T, Feng H, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019;18(1):111. doi:https://doi.org/10.1186/s12943-019-1040-0.
PubMed Web of Science ®Google Scholar
Wang C, Tan S, Liu WR, et al. RNA-seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer. 2019;18(1):134. doi:https://doi.org/10.1186/s12943-019-1061-8.
PubMed Web of Science ®Google Scholar
Kong S, Yang Q, Tang C, et al. Identification of hsa_circ_0001821 as a novel diagnostic biomarker in gastric cancer via comprehensive circular RNA profiling. Front Genet. 2019;10:878. doi:https://doi.org/10.3389/fgene.2019.00878.
PubMed Web of Science ®Google Scholar
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101–1108. doi: https://doi.org/10.1038/nprot.2008.73.
PubMed Web of Science ®Google Scholar
Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. doi:https://doi.org/10.1186/s12943-017-0663-2.
PubMed Web of Science ®Google Scholar
de Acha OP, Rossi M, Gorospe M. Circular RNAs in blood malignancies. Front Mol Biosci. 2020;7:109. doi:https://doi.org/10.3389/fmolb.2020.00109.
PubMed Web of Science ®Google Scholar
Zhang Y, Pisano M, Li N, et al. Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related peripheral neuropathy. Cell Signal. 2021;78:109872. doi:https://doi.org/10.1016/j.cellsig.2020.109872.
PubMed Web of Science ®Google Scholar
Yu S, Ai L, Wei W, et al. CircRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma. Hum Cell. 2021;34(1):219–228. doi:https://doi.org/10.1007/s13577-020-00441-8.
PubMed Web of Science ®Google Scholar
Song Y, Hu N, Song X, et al. Hsa_Circ_0007841 enhances multiple myeloma chemotherapy resistance through upregulating ABCG2. Technol Cancer Res Treat. 2020;19:1533033820928371. doi:https://doi.org/10.1177/1533033820928371.
Web of Science ®Google Scholar
Gao M, Li C, Xiao H, et al. Hsa_circ_0007841: a novel potential biomarker and drug resistance for multiple mmyeloma. Front Oncol. 2019;9:1261. doi:https://doi.org/10.3389/fonc.2019.01261.
PubMed Web of Science ®Google Scholar
Chen S, Ding J, Wang Y, et al. RNA-seq profiling of circular RNAs and the oncogenic role of circPVT1 in cutaneous squamous cell carcinoma. Onco Targets Ther. 2020;13:6777–6788. doi:https://doi.org/10.2147/OTT.S252233.
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date